As many biological products face losing their patents in the next decade, the pharmaceutical industry needs an abbreviated regulatory pathway for approval of biosimilar drug products, which are cost-effective, follow-on/subsequent versions of the innovator's biologic products. But scientific challenges remain due to the complexity of both the manuf
ISBN: | 9781466579705 |
Publication date: | 29th July 2013 |
Author: | Chow, Shein-Chung |
Publisher: | CRC Press |
Format: | Ebook (PDF) |